BGI's Denmark Team Focuses on Clinical Exomes While Parent Company Drives Down WGS Costs – GenomeWeb

BGI's Denmark Team Focuses on Clinical Exomes While Parent Company Drives Down WGS Costs
GenomeWeb
In the meantime, BGI Europe's parent company, BGI Genomics, has been pushing the price of whole-genome sequencing to a record low, announcing a limited-time offer for a $600 genome last month that involves sequencing on its new BGISEQ-500 platform …

Source: Genome Sequencing